A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
252 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Argentino de Diagnóstico Y Tratamiento
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- Centro de Investigación Pergamino Sa
Pergamino, Buenos Aires, Argentina
- Hospital Universitario Austral
Pilar, Buenos Aires, Argentina
- Cemaic - Centro de Especialidades Médicas Ambulatorias E Investigación Clínica
Córdoba, Argentina
- Bankstown-Lidcombe Hospital
Bankstown, New South Wales, Australia
- Genesiscare - North Shore
St Leonards, New South Wales, Australia
- Saint John of God - Subiaco Hospital
Subiaco, Western Australia, Australia
- Universitair Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium
- Algemeen Ziekenhuis Sint-Maarten
Mechelen, Antwerpen, Belgium
- Universitair Ziekenhuis (uz) Leuven - Campus Gasthuisberg
Leuven, Flemish Brabant, Belgium
- Centro Regional Integrado de Oncologia
Fortaleza, Ceará, Brazil
- Nohc - Núcleo de Oncologia E Hematologia Do Ceará - José Lourenço
Fortaleza, Ceará, Brazil
- Centro de Pesquisas Clínicas Em Oncologia - Cpco
Cachoeiro de Itapemirim, Espírito Santo, Brazil
- Hospital Santa Rita
Vitória, Espírito Santo, Brazil
- Núcleo de Oncologia Da Bahia Ondina - Nob
Salvador, Estado de Bahia, Brazil
- Oncoclinicas Oncovida - Brasilia
Brasília, Federal District, Brazil
- Cenantron Centro Avançado de Tratamento Oncológico
Belo Horizonte, Minas Gerais, Brazil
- Cetus Oncologia - Unidade Belo Horizonte
Belo Horizonte, Minas Gerais, Brazil
- Centro Integrado de Oncologia de Curitiba (cionc)
Curitiba, Paraná, Brazil
- Instituto de Medicina Integral Professor Fernando Figueira
Recife, Pernambuco, Brazil
- Centro de Pesquisa Vencer E Oncoclínica - Teresina
Teresina, Piauí, Brazil
- Liga Contra O Câncer - Centro Avançado de Oncologia
Natal, Rio Grande do Norte, Brazil
- Clínica Viver
Centro Santa Maria, Rio Grande do Sul, Brazil
- Hospital Bruno Born
Lajeado, Rio Grande do Sul, Brazil
- Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
- Hospital Mãe de Deus - Centro Integrado de Oncologia
Porto Alegre, Rio Grande do Sul, Brazil
- Irmandade Da Santa Casa de Misericórdia Hospital - Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
- Irmandade Da Santa Casa de Misericórdia Hospital - Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
- Instituto D'Or de Pesquisa E Ensino - Rio de Janeiro
Botafogo, Rio de Janeiro, Brazil
- Grupo Elora
Florianópolis, Santa Catarina, Brazil
- Cho Centro - Centro de Hematologia E Oncologia de Joinville
Joinville, Santa Catarina, Brazil
- Fundação Pio Xii - Hospital de Câncer de Barretos - Hospital de Amor
Barretos, São Paulo, Brazil
- Hospital Amaral Carvalho
Jaú, São Paulo, Brazil
- Instituto de Oncologia de Sorocaba
Sorocaba, São Paulo, Brazil
- A Beneficência Portuguesa de São Paulo
São Paulo, Brazil
- Instituto de Assistência Médica Ao Servidor Público Estadual
São Paulo, Brazil
- Cross Cancer Institute
Edmonton, Alberta, Canada
- William Osler Health System - Brampton Civic Hospital
Brampton, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2025
- Primary completion
- 1 Oct 2029
- Completion
- 1 Oct 2032
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 360
- Registry id
- NCT07128199
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.